Trial Profile

A Proof of Concept Trial of NM 505 in Patients with Type 2 Diabetes

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Jun 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NM 505 (Primary) ; Metformin
Indications Type 2 diabetes mellitus
Focus Adverse reactions; Proof of concept; Therapeutic Use

Most Recent Events

09 Jun 2015 Positive clinical data were presented at the 75th Scientific Sessions of the American Diabetes Association, according to a MicroBiome Therapeutics media release.
07 Apr 2015 According to a MicroBiome Therapeutics media release, results of this trial were published in the Journal of Diabetes Science and Technology.
16 Feb 2015 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com